GHK Cu Peptide Progress: Week 3 Results BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 (compounding only, no legal prescribing) into Category 1. This means A large number of peptides currently being marketed to the public are not FDA approved. These include BPC 157, LL 37, DSIP, Epitalon, GHK Cu (injectable), GHRP 2, GHRP 6, ipamorelin, kisspeptin 10, KPV, melanotan II, PEG MGF, MOTS C, GHK Cu FDA Approval Status 2026: Not Approved